Out today in @CMAJ: @srinmurthy99 + I call out the lack of enforcement of clinical trial registration & results reporting norms by @GovCanHealth.
We argue that market entry should be tied to trial transparency.
https://t.co/iwwlNfVH45
CC @moher_david@NavPersaud@MA_Gagnon
Proud that the Untold Stories grant I received from @ColumbiaMSPH led to the @columbiahpm exhibit celebration on May 2, 2024. Thank you to the students, faculty, and administrators that made this day possible. Looking forward to seeing these plaques displayed in our school!
The class action law suit against the government for cancelling the basic income pilot has been certified. This means that ppl can sue the province.
Participants had improved health & the majority were better able to afford shelter after only a year
https://t.co/VrbqrWWc45
Nearly a year since @HoCCommittees began its study of the PMRPB. The last witnesses (myself & Doug Clark) appeared on May 2, 2023.
And still no report published!
What's the delay?
With the introduction of the Pharmacare Act, I explain why the "Committee of Experts" envisioned in Bill C-64 must be free from conflicts of interest in @IRPP
https://t.co/kYfVo59cwo
@markhollandlib @DonDavies@SteveUBC@NavPersaud@janephilpott
Congratulations to Assistant Prof. @Mina__T on receiving a prestigious appointment as a Tier 2 Canada Research Chair #CRC in Real World Evidence and Pharmaceutical Policy! 🎉 #ImPharmacy#PAM2024
Read the announcement: https://t.co/OoMFgIjnKU
Great to see my letter with Drs. @Swain_WillMD and Luis Gasca @MayoMN_IMRES published in NEJM. We highlight the importance of cultural safety and coordinating medical care with traditional healers to improve Native American health outcomes. https://t.co/8BqMtNqWnK
Please join us on April 16th @ 1:00pm to hear from @NavPersaud as he discusses academic selection and the potential to improve equity through random selection: https://t.co/qsiYeXWcMC
"There are more eponyms named after white men who were Nazis...than all racialized women" -- Gender and racialization status of medical namesakes and why we need to re-examine their use, by Nishaant Bhambra, @SarahWaicus, @NavPersaud https://t.co/ihR2OYtcAw #racism#sexism
The lack of progress on the Canadian Government’s promise to create a national programme for universal access to drugs risks a political crisis.
Paul Webster reports in "Canada’s pharmacare showdown": https://t.co/glem5NB0Ve